Download pdf - Curriculum Vitæwebservices.unime.it/curriculum/uploads/cv_ita_a1f5183a1237d8fdd3... · Indirizzo UOC Neurologia, Policlinico di Messina, Via C. Valeria, 1 - 98125 - Messina (ME)

- 1 -

Curriculum Vitæ

Informazionipersonali

Nome MESSINA Sonia

Indirizzo UOC Neurologia, Policlinico di Messina, Via C. Valeria, 1 - ( )98125 - Messina ME

Telefono 0902212791

Fax 0902212789

E-mail [email protected]

Cittadinanza ITA

Data di nascita 05/05/1976

Titoli di studio

Data diconseguimento

08/04/2009

Titolo conseguito Dottore di ricerca

Voto conseguito 50/50 e lode

Titolo della TesiApprocci terapeutici nella distrofia muscolare di Duchenne: effetti positivi del flavocoxidsulla funzione muscolare e sulla morfologia nel modello murino

Titolo dottorato NEUROSCIENZE CLINICHE

Nome e indirizzoistituzione

Università degli Studi di MESSINA - P.zza S. Pugliatti, 1 - MESSINA


31/10/2005

Titolo conseguito Diploma di scuola di specializzazione

Descrizione Specializzazione in Neuroscienze Cliniche

Voto conseguito 50 / 50 e lode

Titolo della TesiLINIBIZIONE DEL FATTORE NUCLEARE KAPPA-B RIDUCE LADEGENERAZIONE MUSCOLARE E MIGLIORA LE CAPACITÀ FUNZIONALI NELTOPO MDX.




28/07/2000

Titolo conseguito Laurea (vecchio ordin.)

Descrizione MEDICINA E CHIRURGIA

Voto conseguito 110/110 E LODE

Titolo della Tesi "Lo stress ossidativo nella distrofia miotonica"



Esperienze

Periodo 05/10/2011 - oggi

- 2 -

Posizione Ricercatore universitario a t.d.

Qualifica Ricercatore a t.d. (art.1 comma 14 L. 230/05)



Struttura Dip. L.240/2010 NEUROSCIENZE

Periodo 01/05/2009 - 30/04/2013

Posizione Borsista

Tipo di attivitàsvolta

Università di Messina



Periodo 01/01/2007 - 31/12/2009

Posizione Titolare di contratto di ricerca

Qualifica Titolare di contratto di ricerca


Research Fellow del progetto TREAT-NMD (Translational Research in EuropeAssessment and Treatment of Neuromuscular Diseases) (WP09.1. Outcome measures),


U.O. Neuropsichiatria Infantile, Università Cattolica del Sacro Cuore di Roma -

Tipo istituzione Ente di ricerca pubblico italiano

Periodo 02/01/2006 - 31/12/2008

Posizione Dottorando



Struttura Dip. NEUROSCIENZE, SCIENZE PSICHIATRICHE E ANESTESIOLOGICHE


Esperienza Partecipazione a progetto di ricerca


progetto Telethon-UILDM: Classificazione clinica, radiologica ed immunoistochimicadelle forme di distrofia muscolare congenita con ritardo mentale.


Università Cattolica del Sacro Cuore- Roma -


Titolo progettoClassificazione clinica, radiologica ed immunoistochimica delle forme di distrofiamuscolare congenita con ritardo mentale.

Tipo bando Telethon-UILDM

Anno bando 2004

Responsabile U.O. Mercuri

Periodo 01/11/2005 - 01/01/2006

Posizione Dottorando







Progetto Telethon-UILDM: Validazione della scala funzionale Hammersmith nellatrofiamuscolare spinale. Coordinatore Dott. Bertini.


Università Cattolica del Sacro Cuore Roma -

- 3 -


Titolo progetto Validazione della scala funzionale Hammersmith nellatrofia muscolare spinale.

Tipo bando Telethon-UILDM

Anno bando 2004

Responsabile U.O. Mercuri



MIUR. PROGRAMMI DI RICERCA SCIENTIFICA DI RILEVANTE INTERESSENAZIONALE COFIN, Ricerca di tipo Interuniversitario prot. 2004061452. Dallarigenerazione alla ricostruzione del muscolo scheletrico: meccanismi regolatori eapplicazioni terapeutiche.




Titolo progettoDalla rigenerazione alla ricostruzione del muscolo scheletrico: meccanismi regolatori eapplicazioni terapeutiche.

Tipo bando COFIN 2004

Anno bando 2004

Responsabile U.O. Vita

Periodo 02/05/2001 - 31/10/2005

Posizione Specializzando




Periodo 01/04/2003 - 30/09/2005

Posizione Tirocinio o stage

Qualifica Tirocinante o stagista


research fellow presso il Dipartimento di Neurologia , Ospedale Bambin Gesù, Roma


Ospedale Bambin Gesu' di Roma -


Periodo 08/01/2002 - 30/04/2003

Posizione Borsista


research fellow con un British NHS Research Grant presso il Dubowitz NeuromuscularCenter, Imperial College School of Medicine, Hammersmith Hospital, London, UK.


Hammersmith Hospital, Imperial College, Londra -

Tipo istituzione Università straniera

Periodo 09/01/2002 - 30/09/2002

Posizione Tirocinio o stage

Qualifica Tirocinante o stagista


borsa di studio Erasmus, Unità per lo Studio del Sistema Nervoso Vegetativo, pressolIstituto di Neurologia e Neurochirurgia, University College di Londra, Queens Square,London, UK.


University College di Londra -

Tipo istituzione Università straniera

- 4 -

Elenco deiprodotti della

ricerca

Pegoraro E, Bello L, Piva L, Barp L, Ermani M, Politano L,Mercuri E, Previstali S, Torrente Y, Bruno C, Minetti C,Berardinelli A, Comi G, D'Amico A, MESSINA S. (2012).Osteopontin in Duchenne Muscular Dystrophy. ANNALSOF NEUROLOGY; p. 264-264, ISSN: 0364-5134

Bello L., Piva L., Barp A., Taglia A., Picillo E., Vasco G.,Pane M., Previtali S.C., Torrente Y., Gazzerro E., MottaM.C., Grieco G.S., Napolitano S., Magri F., D'Amico A.,Astrea G., MESSINA S., Sframeli M., Vita G.L., Boffi P.,Mongini T., Ferlini A., Gualandi F., Soraru' G., Ermani M.,Vita G., Battini R., Bertini E., Comi G.P., Berardinelli A.,Minetti C., Bruno C., Mercuri E., Politano L., Angelini C.,Hoffman E.P., Pegoraro E. (2012). Importance of SPP1genotype as a covariate in clinical trials in Duchennemuscular dystrophy. . NEUROLOGY, vol. 79; p. 159-162,ISSN: 0028-3878

M. Sframeli, MESSINA S., S. Portaro, M. Dusl, H.Lochmuller, A. Toscano, C. Rodolico (2012). Congenitalmyastenic syndromes due a novel GFPT1 mutation: a newItalian case. ACTA MYOLOGICA, vol. XXXI; p. 95-95, ISSN:1128-2460

FD Tiziano, R. Lomastro, L. Di Pietro, MB Pasanisi, S.Fiori, C. Angelozzi, E. Abiusi, C. Angelini, G. Soraru, A.Gaiani, T. Mongini, L. Vercelli, E. Mercuri, G. Vasco, G.Vita, G.L. Vita, MESSINA S., L. Politano, L. Passamano, G.Di Gregorio, A. Campanella, R. Mantegazza, G. Neri, C.Brahe, L. Morandi. (2012). Morandi. Phase II multicentricdouble-blind placebo controlled study of tolerability andefficacy of salbutamol in adult type III patients. . ACTAMYOLOGICA, vol. XXXI; p. 97-97, ISSN: 1128-2460

N. Licata, MESSINA S., G.L. Vita, M. Sframeli, A. Cama, C.Lo Giudice, S. Romeo, A. Ciranni, M.G. De Pasquale, M.Aguennouz, G. Vita. (2012). Pilot study of flavocoxid inambulant DMD patients. ACTA MYOLOGICA, vol. XXXI; p.82-82, ISSN: 1128-2460

M.G. De Pasquale, MESSINA S., G.L. Vita, A. Cama, A.

- 5 -

Ciranni, C. Lo Giudice, S. Romeo, N. Licata, A. Toscano, M.Aguennouz, G. Vita. (2012). Implication of SIRT1 and itsdownstream pathways in dystrophic process. . ACTAMYOLOGICA, vol. XXXI; p. 78-78, ISSN: 1128-2460

A. Cama, MESSINA S., G.L. Vita, M.G. De Pasquale, A.Ciranni, C. Lo Giudice, S. Romeo, N. Licata, A. Toscano, M.Aguennouz, G. Vita (2012). Role of calcineurin/NFAT onmuscle regeneration in dystrophic process. ACTAMYOLOGICA, vol. XXXI; p. 74-74, ISSN: 1128-2460

C. Bruno, D. Cassandrini, A. D’Amico, M. Pane, L, Maggi,MESSINA S., G.L. Vita, A. Toscano, E. Pegoraro, G. Comi,E. Bertini, E. Mercuri, M. Mora, F.M. Santorelli (2012).Clinical, morphological and genetic data in Italian patientswith congenital myopathy . ACTA MYOLOGICA, vol. XXXI;p. 72-72, ISSN: 1128-2460

A. Barp, L. Bello, L. Piva, G. Soraru, P. Melacini, C. Calore,A. Polo, L. Ferlini, E. Peterle, A. Gaiani, G. Comi, F. Magri,A. Taglia, E. Picillo, L. Politano, MESSINA S., G.L. Vita, G.Vita, K. Gorni, E.P. Hoffman, C. Angelini. (2012). Earliercariomyopathy onset in DMD patients carrying the TTgenotype at SPP1 rs28357094 R. . ACTA MYOLOGICA, vol.XXXI; p. 70-70, ISSN: 1128-2460

Messina MF, MESSINA S., Gaeta M, Rodolico C, SalpietroDamiano AM, Lombardo F, Crisafulli G, De Luca F. (2012).Infantile spinal muscular atrophy with respiratory distresstype I (SMARD 1): an atypical phenotype and review of theliterature. . EUROPEAN JOURNAL OF PAEDIATRICNEUROLOGY; p. 90-94, ISSN: 1090-3798

Gaeta M, MESSINA S., Mileto A, Vita GL, Ascenti G, VinciS, Bottari A, Vita G, Settineri N, Bruschetta D, RacchiusaS, Minutoli F. (2012). Muscle Fat-Fraction and Mapping inDuchenne Muscular Dystrophy: Evaluation of DiseaseDistribution and Correlation with Clinical Assessments: Apreliminary experience. SKELETAL RADIOLOGY, vol. 41;p. 955-961, ISSN: 0364-2348, doi:10.1007/s00256-011-1301-5

Barone R, Aiello C, Race V, Morava E, Foulquier F,Riemersma M, Passarelli C, Concolino D, Carella M,Santorelli F, Vleugels W, Mercuri E, Garozzo D, Sturiale L,MESSINA S., Jaeken J, Fiumara A, Wevers RA, Bertini E,

- 6 -

Matthijs G, Lefeber DJ. (2012). A musculardystrophy-dystroglycanopathy syndrome with severeepilepsy. ANNALS OF NEUROLOGY, vol. 72; p. 550-558,ISSN: 0364-5134, doi: 10.1002/ana.23632

Tiziano F.D., Lomastro R., Di Pietro L., Barbara PasanisiM., Fiori S., Angelozzi C., Abiusi E., Angelini C., Sorarù G.,Gaiani A., Mongini T., Vercelli L., Vasco G., Vita G., Vita G.L., MESSINA S., Politano L., Passamano L., Di Gregorio G.,Montomoli C., Orsi C., Campanella A., Mantegazza R.,Morandi L. (2012). Clinical and molecular cross-sectionalstudy of a cohort of adult type III spinal muscular atrophypatients: clues from a biomarker study. . EUROPEANJOURNAL OF HUMAN GENETICS; p. 1-7, ISSN:1018-4813, doi: 10.1038/ejhg.2012.233.

Pane M., MESSINA S., Vasco G., Foley A.R., Morandi L.,Pegoraro E., Mongini T., D'Amico A., Bianco F., LombardoM.E., Scalise R., Bruno C., Berardinelli A., Pini A., MoroniI., Mora M., Toscano A., Moggio M., Comi G., SantorelliF.M., Bertini E., Muntoni F., Mercuri E. (2012).Respiratory and cardiac function in congenital musculardystrophies with alpha dystroglycan deficiency.NEUROMUSCULAR DISORDERS, vol. 22; p. 685-689,ISSN: 0960-8966, doi: 10.1016/j.nmd.2012.05.006

Barca E., Aguennouz M., Mazzeo A., MESSINA S., ToscanoA., Vita GL., Portaro S., Parisi D., Rodolico C. (2012).ANT1 is reduced in sporadic inclusion body myositis.NEUROLOGICAL SCIENCES; p. 1-10, ISSN: 1590-1874,doi: 10.1007/s10072-012-0976-2

Bianco F, Pane M, Vasco G, Tiziano D, Mongini T, AngeliniC, Soraru G, MESSINA S., Vita G, Morandi L. (2012).24-Holter ECG in type II and III SMA. NEUROMUSCULARDISORDERS; p. 894-894, ISSN: 0960-8966

Mazzone ES, Pane M, Scalise R, Sormani MP, Torrente Y,Berardinelli A, MESSINA S., Vita G, Mercuri E. (2012).Functional changes in Duchenne muscular dystrophy: a 24month longitudinal cohort study. NEUROMUSCULARDISORDERS; p. 876-876, ISSN: 0960-8966

Pane M, MESSINA S., Bruno C, Mercuri E, Vita GL, RicottiV. (2012). Duchenne muscular dystrophy and epilepsy. .NEUROMUSCULAR DISORDERS; p. 886-886, ISSN:

- 7 -

0960-8966

MESSINA S., Vita GL, De Pasquale MG, Cama A, Licata A,Romeo S, Tiranni A, Lo Giudice C, Toscano A, AguennouzM, Vita G. (2012). Implication of SIRT1 and itsdownstream pathways in dystrophic process.NEUROMUSCULAR DISORDERS; p. 864-864, ISSN:0960-8966

MESSINA S., Vita GL, Sframeli M, Licata N, Cama L,Ciranni A, S. Romeo, Aguennouz M, Vita G. (2012). Pilotstudy of flavocoxid in ambulant DMD patients. .NEUROMUSCULAR DISORDERS; p. 864-864, ISSN:0960-8966

Mazzone E, Vasco G, Sormani MP, Torrente Y, BerardinelliA, MESSINA S., D'Amico A, Doglio L, Politano L, CavallaroF, Frosini S, Bello L, Bonfiglio S, Zucchini E, De Sanctis R,Scutifero M, Bianco F, Rossi F, Motta MC, Sacco A, DonatiMA, Mongini T, Pini A, Battini R, Pegoraro E, Pane M,Gasperini S, Previtali S, Napolitano S, Martinelli D, BrunoC, Vita G, Comi G, Bertini E, Mercuri E. (2011). Functionalchanges in Duchenne muscular dystrophy: A 12-monthlongitudinal cohort study. . NEUROLOGY, vol. 77; p.250-256, ISSN: 0028-3878

Bitto A., Altavilla D., MESSINA S., Polito F., Irrera N.,Marini H., Squadrito F. (2011). The soy isoflavonegenistein promotes muscle regeneration acting on cellcycle and apoptosis in mdx mice. In: -. Bologna,14-17/09/2011, p. ND-ND

MESSINA S., VITA GL, RODOLICO C, TOSCANO A,GAETA M, MILETO A (2011). (2011). Dual-echo dual flipangle gradient-echo MRI technique for quantification ofmuscle fat fraction in Duchenne muscular dystrophy: anew valuable outcome measure. NEUROMUSCULARDISORDERS, vol. 21; p. 654-654, ISSN: 0960-8966

VITA GL, MESSINA S., RODOLICO C, TOSCANO A,MILETO A, GAETA M, VITA G (2011). Dual-echo dual flipangle gradient-echo MRI technique for quantification ofmuscle fat fraction in Duchenne muscular dystrophy: anew valuable outcome measure. NEUROLOGICALSCIENCES, vol. 32; p. s58-s58, ISSN: 1590-1874

- 8 -

Aguennouz M, Vita GL, MESSINA S., Cama A, Lanzano N,Ciranni A, Rodolico C, Di Giorgio RM, Vita G. (2011).Telomere shortening is associated to TRF1 and PARP1overexpression in Duchenne muscular dystrophy .NEUROBIOLOGY OF AGING, vol. 32; p. 2190-2197, ISSN:0197-4580, doi: 10.1016/j.neurobiolaging. 2010.01.008

MESSINA S., Bitto A, Aguennouz M, Vita GL, Polito F,Irrera N, Altavilla D, Marini H, Migliorato A, Squadrito F,Vita G. (2011). The soy isoflavone genistein blunts nuclearfactor kappa-B, MAPKs and TNF-a activation andameliorates muscle function and morphology in mdx mice.NEUROMUSCULAR DISORDERS, vol. 21; p. 579-589,ISSN: 0960-8966

Di Rosa G, MESSINA S., D'Amico A, Bertini E, Pustorino G,Spanò M, Tortorella G. (2011). A new form ofalpha-dystroglycanopathy associated with severedrug-resistant epilepsy and unusual EEG features.EPILEPTIC DISORDERS, vol. 13; p. 259-262, ISSN:1294-9361, doi: 10.1684/epd.2011.0461

MAZZONE E, BIANCO F, MARTINELLI D, GLANZMANAM, MESSINA S., SANCTIS RD, MAIN M, EAGLE M,FLORENCE J, KROSSCHELL K, VASCO G, PELLICCIONIM, LOMBARDO M, PANE M, FINKEL R, MUNTONI F,BERTINI E, MERCURI E. (2011). Assessing upper limbfunction in nonambulant SMA patients: Development of anew module. NEUROMUSCULAR DISORDERS; p.406-412, ISSN: 0960-8966

MESSINA S., Vita GL, Aguennouz M, Sframeli M, RomeoS, Rodolico C, Vita G. (2011). Activation of NF-kappaBpathway in Duchenne muscular dystrophy: relation to age.ACTA MYOLOGICA, vol. 30; p. 16-23, ISSN: 1128-2460

MERCURI E, CLEMENTS E, OFFIAH A, PICHIECCHIO A,VASCO G, BIANCO F, BERARDINELLI A, MANZUR A,PANE M, MESSINA S., GUALANDI F, RICCI E,RUTHERFORD M, MUNTONI F. (2010). Muscle magneticresonance imaging involvement in muscular dystrophieswith rigidity of the spine. ANNALS OF NEUROLOGY; p.201-208, ISSN: 0364-5134

TIZIANO FD, PINTO AM, FIORI S, LOMASTRO R,MESSINA S., BRUNO C, PINI A, PANE M, D'AMICO A,

- 9 -

GHEZZO A, BERTINI E, MERCURI E, NERI G, BRAHE C.(2010). SMN transcript levels in leukocytes of SMApatients determined by absolute real-time PCR.EUROPEAN JOURNAL OF HUMAN GENETICS, vol. 18; p.52-58, ISSN: 1018-4813

GLANZMAN, AM, MAZZONE E, MAIN M, PELLICCIONIM, WOOD J, SWOBODA KJ, SCOTT C, PANE M, MESSINAS., BERTINI E, MERCURI E AND FINKEL RS. (2010). TheChildren’s Hospital of Philadelphia Infant Test ofNeuromuscular Disorders (CHOP INTEND): Testdevelopment and reliability. NEUROMUSCULARDISORDERS; p. 155-161, ISSN: 0960-8966

MAZZONE E, MARTINELLI D, BERARDINELLI A,MESSINA S., D'AMICO A, VASCO G, MAIN M, DOGLIO L,POLITANO L, CAVALLARO F, FROSINI S, BELLO L,CARLESI A, BONETTI AM, ZUCCHINI E, SANCTIS RD,SCUTIFERO M, BIANCO F, ROSSI F, MOTTA MC, SACCOA, DONATI MA, MONGINI T, PINI A, BATTINI R,PEGORARO E, PANE M, PASQUINI E, BRUNO C, VITA G,WAURE CD, BERTINI E, MERCURI E. (2010). North StarAmbulatory Assessment, 6-minute walk test and timeditems in ambulant boys with Duchenne musculardystrophy. NEUROMUSCULAR DISORDERS, vol. 20; p.712-716, ISSN: 0960-8966

TIZIANO FD, LO MASTRO R, PINTO A, MESSINA S.,D&#X2019, AMICO A, FIORI S, ANGELOZZI C, PANE M,MERCURI E, BERTINI E, NERI G, BRAHE C. (2010).Salbutamol increases SMN transcript levels in leukocytesof spinal muscular atrophy patients: relevance for clinicaltrial design. JOURNAL OF MEDICAL GENETICS, vol. 12;p. 856-858, ISSN: 0022-2593

BELCASTRO V, GALLETTI F, GIUGLIETTI M, MESSINAS., ELIA M, PRONTERA P, CALABRESI P. (2010). Seizureaggravation caused by antiepileptic drugs in a patient withmuscle-eye-brain disease. EPILEPSY & BEHAVIOR, vol.19; p. 666-668, ISSN: 1525-5050

MESSINA S., Bruno C, Moroni I, Pegoraro E, D'Amico A,Biancheri R, Berardinelli A, Boffi P, Cassandrini D, FarinaL, Minetti C, Moggio M, Mongini T, Mottarelli E, Pane M,Pantaleoni C, Pichiecchio A, Pini A, Ricci E, Saredi S,

- 10 -

Sframeli M, Tortorella G, Toscano A, Trevisan CP, UggettiC, Vasco G, Comi GP, Santorelli FM, Bertini E, Mercuri E.(2010). Congenital muscular dystrophies with cognitiveimpairment. A population study. NEUROLOGY, vol. 75; p.898-903, ISSN: 0028-3878

MESSINA S., Vita GL, Bitto A, Aguennouz M, Squadrito F,Vita G. (2010). The soy isoflavone genistein promotesmuscle regeneration and function acting on cell cycle andapoptosis in mdx mice. . NEUROMUSCULAR DISORDERS;p. 656-656, ISSN: 0960-8966

MESSINA S., Vita GL, Bitto A, Aguennouz M, Romeo S,Pontoriero D, Cozzoli A, Capogrosso R, Sbendorio V, DeLuca A, Vita G. (2010). Telomere length in exercised wildtype and mdx mice. . NEUROMUSCULAR DISORDERS; p.656-656, ISSN: 0960-8966

Vita GL, MESSINA S., Aguennouz M, Romeo S, PontorieroD, Cozzoli A, Capogrosso R, Sbendorio V, De Luca A, VitaG. (2010). Telomere length in exercised wild type and mdxmice. . NEUROLOGICAL SCIENCES, vol. 31; p. S46-S46,ISSN: 1590-1874

MESSINA S., GL Vita, A Bitto, M Aguennouz, F Squadrito,G Vita. (2010). The soy isoflavones genistein promotesmuscle regeneration and function acting on cell cycle andapoptosis in mdx mice. NEUROLOGICAL SCIENCES, vol.31; p. S105-S105, ISSN: 1590-1874

MESSINA S., Tortorella G, Concolino D, Spanò M, D’AmicoA, Bruno C, Santorelli FM, Mercuri E, Bertini E (2010).Distrofie muscolari congenite con ritardo mentale: lostudio della popolazione italiana. ACTA MYOLOGICA; p.12-12, ISSN: 1128-2460

Francesco Squadrito, Alessandra bitto, Giuseppe Vita,MESSINA S., Bruce P. Burnett (2010). Methods of treatingDuchenne muscular dystrophy with flavonoids.12/693,711. Primus Pharmaceuticals, Inc.

MESSINA S., Tortorella G, Spano’ M (2009). Congenitalmuscular dystrophies with defective of dystroglycanglycosylation, cerebellar hupoplasia and severe epilepsy.NEUROMUSCULAR DISORDERS; p. 553-553, ISSN:0960-8966

- 11 -

Gualandi F, Urciolo A, Martoni E, Sabatelli P, Squarzoni S,Bovolenta M, MESSINA S. (2009). Autosomal recessiveBethlem myopathy. . NEUROMUSCULAR DISORDERS; p.608-608, ISSN: 0960-8966

Mazzone ES, MESSINA S., Vasco G (2009). Reliability ofthe North Star Ambulatory assessment in a multicentricsetting. NEUROMUSCULAR DISORDERS; p. 571-571,ISSN: 0960-8966

Mercuri E, Clement E, Offiah A, Pichiecchio A, Alsopp J,Vasco G, Bianco F, Manzur A, MESSINA S. (2009).Mercuri E, Clement E, Offiah A, Pichiecchio A, Alsopp J,Vasco G, Bianco F, Manzur A, Messina S.NEUROMUSCULAR DISORDERS; p. 627-627, ISSN:0960-8966

MESSINA S., Aguennouz M, Mazzeo A, Vita G (2009).Nuclear factor-kappaB, mitogen-activated protein kinasesand cyclooxygenase/5-lipoxygenase pathway inhibition byflavocoxid improves muscle function and morphology inmdx mice: a comparison study with methylprednisolone.NEUROMUSCULAR DISORDERS; p. 583-583, ISSN:0960-8966

Mercuri E.*, MESSINA S. (2009). Congenital musculardystrophies with defective glycosylation of dystroglycan: apopulation study. NEUROLOGY, vol. 72; p. 1802-1809,ISSN: 0028-3878

GUALANDI F, URCIUOLO A, MARTONI E, SABATELLI P,SQUARZONI S, BOVOLENTA M, MESSINA S., MERCURIE, FERLINI A, BONALDO P, MERLINI L (2009). Autosomalrecessive Bethlem myopathy. NEUROLOGY, vol. 73; p.1883-1891, ISSN: 0028-3878

MESSINA S., Aguennouz M, Mazzeo A, Migliorato A, BittoA, Vita GL, Russo M, Rizzuto E, Musarò A, Squadrito F,Vita G. (2009). Nuclear factor-kappaB, mitogen-activatedprotein kinases and cyclooxygenase/5-lipoxygenasepathway inhibition by flavocoxid improves muscle functionand morphology in mdx mice: a comparison study withmethylprednisolone. NEUROMUSCULAR DISORDERS; p.583-583, ISSN: 0960-8966

- 12 -

MESSINA S., Aguennouz M, Bitto A, Mazzeo A., MiglioratoA, Vita GL, Russo M, De Pasquale MG, Naro A, Rizzuto E,Musarò F, Squadrito F, Vita G. (2009). L'inibizione deipathway del fattore nucleare-kappaB, delle MAP chinasi edi COX/5-LOX mediante trattamento con flavocoxidmigliora la funzione e la morfologia muscolare nel topomdx: uno studio comparativo con il metilprednisolone. In:-. Verona, 11-13 Giugno 2009

MESSINA S., Tortorella G, Concolino D, Spanò M, D’AmicoA, Bruno C, Santorelli FM, Mercuri E, Bertini E. (2009).Una nuova forma di distrofia muscolare congenita conalterata glicosilazione dell'a-distroglicano, ipoplasiacerebellare ed epilessia severa. . In: -. Verona, 11-13Giugno 2009

MESSINA S., G. Tortorella, D. Concolino, M. Spano', A.D’Amico, C. Bruno, F.M. Santorelli, E. Mercuri, E. Bertini(2009). CONGENITAL MUSCULAR DYSTROPHY WITHDEFECTIVE -DYSTROGLYCAN, CEREBELLARHYPOPLASIA, AND EPILEPSY. NEUROLOGY, vol. 73; p.1599-1601, ISSN: 0028-3878

MESSINA S., Bitto A, Aguennouz M, Mazzeo A, MiglioratoA, Polito F, Irrera N, Altavilla D, Vita GL, Russo M, Naro A,De Pasquale MG, Rizzuto E, Musarò A, Squadrito F, VitaG. (2009). Flavocoxid counteracts muscle necrosis andimproves functional properties in mdx mice: a comparisonstudy with methylprednisolone. EXPERIMENTALNEUROLOGY, vol. 220; p. 349-358, ISSN: 0014-4886, doi:10.1016/j.expneurol.2009.09.015

PADUA L, APRILE I, FRUSCIANTE R, IANNACCONE E,ROSSI M, RENNA R, MESSINA S., FRASCA G, RICCI E.(2009). Quality of Life and Pain in patients withFacioscapulohumeral Muscular Dystrophy. MUSCLE &NERVE, vol. 40; p. 200-205, ISSN: 0148-639X

Mazzone ES*, MESSINA S. (2009). Reliability of the NorthStar Ambulatory Assessment in a multicentric setting.NEUROMUSCULAR DISORDERS, vol. 19; p. 458-461,ISSN: 0960-8966

PANE M, STACCIOLI S, MESSINA S., Mercuri E. (2008).Salbutamolo in regime quotidiano in bambini con atrofiamuscolare spinale tipo II. BASIC AND APPLIED

- 13 -

MYOLOGY; p. 12-15, ISSN: 1120-9992

PANE M, STACCIOLI S, MESSINA S., D'AMICO A,PELLICCIONI M, MAZZONE ES, CUTTINI M, ALFIERI P,BATTINI R, MAIN M, MUNTONI F, BERTINI E,VILLANOVA M, MERCURI E. (2008). Daily salbutamol inyoung patients with SMA type II. NEUROMUSCULARDISORDERS, vol. 18; p. 536-540, ISSN: 0960-8966

MESSINA S., MAZZEO A, BITTO A, AGUENNOUZ M,MIGLIORATO A, DE PASQUALE MG, SQUADRITO F, VITAG (2008). Medical food in mdx mice: isoflavonesameliorate muscle function and pathology.NEUROLOGICAL SCIENCES, vol. 27; p. 135-135, ISSN:1590-1874

MESSINA S., Mazzeo A., Bitto A., Aguennouz M,Migliorato A, De Pasquale MG, Squadrito F, Vita G. (2008).Medical food in mdx mice: genistein and flavocoxidameliorate muscle pathology and function. . EUROPEANJOURNAL OF NEUROLOGY; p. 23-23, ISSN: 1468-1331

MESSINA S., MAZZEO A, BITTO A, AGUENNOUZ M,MIGLIORATO A, DE PASQUALE MG, SQUADRITO F, VITAG (2008). Medical food in mdx mice: genistein andflavocoxid ameliorates muscle pathology and function. In:Myology. Marsiglia, France, 25-29/05/ 2008, p. 15-16

MESSINA S., MAZZEO A, BITTO A, AGUENNOUZ M,MIGLIORATO A, DE PASQUALE MG, SQUADRITO F, VITAG (2008). Enhancing muscle regeneration: beneficialeffects of genistein and flavocoxid. In: -. Messina, 22settembre 2008, p. 28-30

MERCURI E, MESSINA S., PANE M, BERTINI E (2008).Current methodological issues in the study of childrenwith inherited neuromuscular disorders.DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY,vol. 50; p. 417-421, ISSN: 0012-1622

MESSINA S., PANE M, DE ROSE P, VASTA I, SORLETI D,ALOYSIUS A, SCIARRA F, MANGIOLA F, KINALI M,BERTINI E, MERCURI E (2008). Feeding problems andmalnutrition in Spinal Muscular Atrophy type II.NEUROMUSCULAR DISORDERS, vol. 18; p. 389-393,ISSN: 0960-8966

- 14 -

DAMICO A, CUTTINI M, RAVÀ L, MERCURI E, MESSINAS., PANE M, MASTELLA C, CHIARINI TESTA B, BRAHJEC, TIZIANO D, VITA G, BERTINI E (2008). Clinical factorsas predictors of survival in spinal muscular atrophy type I.JOURNAL OF PAEDIATRICS AND CHILD HEALTH, vol.18; p. S1-, ISSN: 1034-4810

MESSINA S., MORA M, PEGORARO E, PINI A, MONGINIT, DAMICO A, PANE M, AIELLO C, BRUNO C,BIANCHERI R, BERARDINELLI A, BOITO C, FARINA L,MORANDI L, MORONI I, PEZZANI R, PICHIECCHIO A,RUGGIERI A, SAREDI S, SCUDERI C, TESSA A, TOSCANOA, TORTORELLA G, TREVISAN C.P, UGGETTI C,SANTORELLI FM, BERTINI E, MERCURI E (2008).POMT1 and POMT2 mutations in CMD patients: amulticentric Italian study. NEUROMUSCULARDISORDERS, vol. 18; p. 565-571, ISSN: 0960-8966

MERCURI E, MAYHEW A, MUNTONI F, MESSINA S.,STRAUB V, VAN OMMEN GJ, VOIT T, BERTINI E,BUSHBY K (2008). Report of three expert workshops:TREAT-NMD/ENMC Workshop on outcome measures,12th-13th May 2007, Naarden, The Netherlands;TREAT-NMD Workshop on outcome measures inexperimental trials for DMD, 30th June-1st July 2007,Naarden, The Netherlands; Conjoint Institute of MyologyTREAT-NMD Meeting on physical activity monitoring inneuromuscular disorders, 11th July 2007, Paris, France.NEUROMUSCULAR DISORDERS, vol. 18; p. 894-903,ISSN: 0960-8966

MARTONI A, SABATELLI P, FABRIS M, MERCURI E,PANE M, MESSINA S., Gualandi F, Ferlini A. (2008). Acomprehensive molecular approach in COLA6 relatedmyopathies based on genomic sequencing, transcriptionalanalysis and array CGH. NEUROMUSCULAR DISORDERS;p. 125-125, ISSN: 0960-8966

MARTONI A, SABATELLI P, FABRIS M, MERCURI E,PANE M, MESSINA S., GUALANDI F, FERLINI A (2008).Caratterizzazione molecolare nelle miopatie da COLA6mediante sequenziamento estensivo, analisi trascrizionaleed array CGH. BASIC AND APPLIED MYOLOGY, vol. 18; p.133-133, ISSN: 1120-9992

- 15 -

MESSINA S., Bruno C, Mora M, Pegoraro E, Comi GP,D'Amico A, Aiello C, Biancheri R, Berardinelli A, Boffi P,Cassandrini D, Laverda A, Moggio M, Morandi L, Moroni I,Pane M, Pezzani R, Pichiecchio A, Pini A, Minetti C,Mongini T, Mottarelli E, Ricci E, Ruggieri A, Saredi S,Scuderi C, Tessa A, Toscano A, Tortorella G, Trevisan CP,Uggetti C, Vasco G, Santorelli FM, Bertini E. (2008).Correlazioni genotipo-fenotipo nelle distrofie muscolaricongenite con riduzione dell'alfa-distroglicano: uno studioitaliano multicentrico. BASIC AND APPLIED MYOLOGY; p.23-27, ISSN: 1120-9992

MESSINA S., Bruno C, Mora M, Pegoraro E, Comi GP,D'Amico A, Aiello C, Biancheri R, Berardinelli A, Boffi P,Cassandrini D, Laverda A, Moggio M, Morandi L, Moroni I,Pane M, Pezzani R, Pichiecchio A, Pini A, Minetti C,Mongini T, Mottarelli E, Ricci E, Ruggieri A, Saredi S,Scuderi C, Tessa A, Toscano A, Trevisan CP, Uggetti C,Vasco G, Santorelli FM, Bertini E. (2008).Genotype-phenotype correlations in congenital musculardystrophies with defective glycosylation of dystroglycan: amulticentric study. NEUROMUSCULAR DISORDERS, vol.18; p. 735-735, ISSN: 0960-8966

MESSINA S., Bruno C, Mora M, Pegoraro E, Comi GP,D'Amico A, Aiello C, Biancheri R, Berardinelli A, Boffi P,Cassandrini D, Laverda A, Moggio M, Morandi L, Moroni I,Pane M, Pezzani R, Pichiecchio A, Pini A, Minetti C,Mongini T, Mottarelli E, Ricci E, Ruggieri A, Saredi S,Scuderi C, Tessa A, Toscano A, Tortorella G, Trevisan CP,Uggetti C, Vasco G, Santorelli FM, Bertini E. (2008).Genotype-phenotype correlations in congenital musculardystrophies with defective glycosylation of dystroglycan: amulticentric study. NEUROLOGICAL SCIENCES, vol. 27;p. 125-125, ISSN: 1590-1874

PANE M, STACCIOLI S, MESSINA S. (2008). Dailysalbutamol in young patients with SMA type II.NEUROMUSCULAR DISORDERS, vol. 18; p. 762-762,ISSN: 0960-8966

MESSINA S., PANE M, DE ROSE P, VASTA I, SORLETI D,SCIARRA F, MANGIOLA F, MERCURI E. (2007). Feeding

- 16 -

problems and weight gain in spinal muscular atrophy.NEUROMUSCULAR DISORDERS; p. 774-774, ISSN:0960-8966

MESSINA S., MAZZEO A, BITTO A., AGUENNOUZ M,MIGLIORATO A, DE PASQUALE MG, MINUTOLI L,ALTAVILLA D, ZENTILIN L, GIACCA M, SQUADRITO F,VITA G (2007). VEGF overexpression via adeno-associatedvirus gene transfer promotes skeletal muscle regenerationand enhances muscle function in mdx mice. FASEBJOURNAL, vol. 21; p. 3737-3746, ISSN: 0892-6638

MERCURI E, PANE M, MESSINA S., BERARDINELLI A(2007). Mental retardation in patients with neuromusculardisorders. MONTROUGE: John Libbey Eurotext, p. 33-48,ISBN: 9782742004836

TURTURRO F, A. MONTANARO, L. LABIANCA, M.SPOLETINI, F. MANGIOLA, F. SCIARRA, MESSINA S., A.FERRETTI (2007). Trattamento chirurgico delle scoliosi inpazienti affetti da distrofia muscolare di Duchenne. In: -.Bologna, 11-15 /11/ 2007, p. 233-234

MESSINA S., MAZZEO A., BITTO A, AGUENNOUZ M,MIGLIORATO A, MONICI M, DE PASQUALE M,SQUADRITO F, VITA G (2007). Medical food in mdx mice:isoflavones ameliorate muscle function and pathology. In:-. Giardini Naxos, 17-20 ottobre 2007, vol. 17, p. 803-804

TURTURRO F, MONTANARO A, LA BIANCA L, SPOLETINIM, MANGIOLA F, SCIARRA F, MESSINA S., FERRETTI A(2007). The surgical treatment of scoliosis in DuchenneMuscular Dystrophy. In: J Child Orthop. Sorrento,11–14/04/2007, p. S130-S132

MERCURI E, BERTINI E, MESSINA S., SOLARI A,DAMICO A, ANGELOZZI C, BATTINI R, BERARDINELLI A,BOFFI P, BRUNO C, CINI C, COLITTO F, KINALI M,MINETTI C, MONGINI T, MORANDI L, NERI G, ORCESIS, PANE M, PELLICCIONI M, PINI A, TIZIANO FD,VILLANOVA M, VITA G., BRAHE C (2007). Randomized,double-blind, placebo-controlled trial of phenylbutyrate inspinal muscular atrophy. NEUROLOGY, vol. 68; p. 51-55,ISSN: 0028-3878

KINALI M, MAIN M, ELIAHOO J, MESSINA S., KNIGHT

- 17 -

RK, LEHOVSKY J, EDGE G, MERCURI E, MANZUR AY,MUNTONI F (2007). Predictive factors for thedevelopment of scoliosis in Duchenne muscular dystrophy.EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY,ISSN: 1090-3798

TIZIANO FD, BERTINI E, MESSINA S., SOLARI A,ANGELOZZI C, PANE M, D'AMICO A, ALFIERI P, FIORI S,BATTINI R, BERARDINELLI A, BOFFI P, BRUNO C, CINIC, MINETTI C, MONGINI T, MORANDI L, ORCESI S,PELLICCIONI M, PINI A, VILLANOVA M, VITA G.,LOCATELLI M, MERCURI E, BRAHE C (2007). TheHammersmith functional score correlates with the SMN2copy number: a multicentric study. NEUROMUSCULARDISORDERS, vol. 17; p. 400-403, ISSN: 0960-8966

ZHOU H, JUNGBLUTH H, SEWRY CA, FENG L, BERTINIE, BUSHBY K, STRAUB V, ROPER H, ROSE MR,BROCKINGTON M, KINALI M, MANZUR A, ROBB S,APPLETON R, MESSINA S., D'AMICO A, QUINLIVAN R,SWASH M, MULLER CR, BROWN S, TREVES S,MUNTONI F (2007). Molecular mechanisms andphenotypic variation in RYR1-related congenitalmyopathies. BRAIN, vol. 130; p. 2024-2036, ISSN:0006-8950

MESSINA S., MAZZEO A, BITTO A, AGUENNOUZ M,MIGLIORATO A, DE PASQUALE MG, MINUTOLI L,ALTAVILLA D, ZENTILIN L, GIACCA M, SQUADRITO F,VITA G (2007). VEGF overexpression via adeno-associatedvirus gene transfer promotes skeletal muscle regenerationand enhances muscle function in mdx mice. FASEBJOURNAL, vol. 21; p. 3737-3746, ISSN: 0892-6638

MERCURI E, PICHIECCHIO A, ALLSOP J, MESSINA S.,PANE M, RUTHERFORD M, MUNTONI F (2007). MuscleMRI in inherited neuromuscular disorders: past, presentand future. JOURNAL OF MAGNETIC RESONANCEIMAGING, vol. 25; p. 433-440, ISSN: 1053-1807

MAZZONE E, MESSINA S., Vasco G, Main M, Eagle M,D'Amico A, Doglio L, Politano L, Cavallaro F, Frosini S,Bello L, Magri F, Corlatti A, Zucchini E, Brancalion B,Rossi F, Ferretti M, Motta MG, Cecio MR, Berardinelli A,Alfieri P, Mongini T, Pini A, Astrea G, Battini R, Comi G,

- 18 -

Pegoraro E, Morandi L, Pane M, Angelini C, Bruno C,Villanova M, Vita G, Donati MA, Bertini E, Mercuri E.(2007). Development of a upper limb gross motorfunctional scale for neuromuscular patients.NEUROMUSCULAR DISORDERS; p. 894-894, ISSN:0960-8966

MESSINA S., Mora M, Pegoraro E, Pini A, Mongini T,D’Amico A, Pane M, Aiello C, Bruno C, Biancheri R,Berardinelli A, Boito C, Farina L, Morandi L, Moroni I,Pezzani R, Pichiecchio A, Ruggieri A, Saredi S, Scuderi C,Tessa A, Toscano A, Trevisan C.P., Uggetti C, SantorelliFM, Bertini E, Mercuri E. (2007). Expanding the clinicalspectrum of POMT1 and POMT2 phenotype: a multicentricstudy in the Italian population. NEUROMUSCULARDISORDERS; p. 869-869, ISSN: 0960-8966

MARTONI A, SABATELLI P, FABRIS M, MERCURI E,PANE M, MESSINA S., Gualandi F, Melini L, Ferlini A(2007). Molecular analysis of COLA6 genes in patientswith Bethlem myopathy and Ulrich congenital musculardstrophy. NEUROMUSCULAR DISORDERS; p. 713-713,ISSN: 0960-8966

MESSINA S., Mora M, Pegoraro E, Pini A, Mongini T,D’Amico A, Pane M, Aiello C, Bruno C, Biancheri R,Berardinelli A, Boito C, Farina L, Morandi L, Moroni I,Pezzani R, Pichiecchio A, Ruggieri A, Saredi S, Scuderi C,Tessa A, Toscano A, Tortorella G, Trevisan C.P., Uggetti C,Santorelli FM, Bertini E, Mercuri E. (2007). Expanding theclinical spectrum of POMT1 and POMT2 phenotype: amulticentric study in the Italian population. BASIC ANDAPPLIED MYOLOGY, vol. 19; p. 112-112, ISSN: 1120-9992

MESSINA S., Mazzeo A, Bitto A, Aguennouz M, MiglioratoA, Monici M, De Pasquale M, Squadrito F, Vita G. (2007).Medical food in mdx mice: isoflavones ameliorate musclefunction and pathology. . NEUROMUSCULARDISORDERS; p. 803-804, ISSN: 0960-8966

BERTINI E, ANGELOZZI C, MESSINA S., DAMICO A,BATTINI R, BERARDINELLI A, BOFFI P, BRUNO C, CINIC, COLITTO F, MINETTI M, MONGINI T, MORANDIL,NERI G, ORCESI S, PANE M, PELLICCIONI M, PINI A,TIZIANO FD, VILLANOVA M, VITA G., MERCURI E,

- 19 -

BRAHE C. (2006). Correlation between the Hammersmithfunctional motor scale and SMN 2 copy number in amulticentric study. BASIC AND APPLIED MYOLOGY; p.43-43, ISSN: 1120-9992

MESSINA S., ALTAVILLA D, AGUENNOUZ M, SEMINARAP, MINUTOLI L., MONICI MC, BITTO A, MAZZEO A,MARINI H, SQUADRITO F, VITA G (2006). Lipidperoxidation inhibition blunts nuclear factor-kappa Bactivation, reduces skeletal muscle degeneration, andenhances muscle function in mdx mice. AMERICANJOURNAL OF PATHOLOGY, vol. 168; p. 918-926, ISSN:0002-9440

MESSINA S., AGUENNOUZ M, BITTO A, MIGLIORATO A,GIACCA M, SQUADRITO F, VITA G. (2006). Vascularendothelial growth factor gene transfer usingadeno-associated viral vectors stimulates skeletal muscleregeneration and enhances muscle function in mdx mice.In: -. Bari, 14-18 ottobre 2006, vol. 27(Suppl), p. S20-S21,ISBN/ISSN: 1590-1874

MESSINA S., AGUENNOUZ M, BITTO A, MIGLIORATO A,GIACCA M, SQUADRITO F, VITA G (2006). Vascularendothelial growth factor gene transfer usingadeno-associated viral vectors stimulates skeletal muscleregeneration and enhances muscle function in mdx mice.In: Basic and Applied Myology. Rome, 16-18/5/2006, p.111-111

MERCURI E, BERTINI E, MESSINA S., DAMICO A,SOLARI A, ANGELOZZI C, BATTINI R, BERARDINELLI A,BOFFI P, BRUNO C, CINI C, COLITTO F, MINETTI C,MONGINI T, MORANDI L, NERI G, ORCESI S, PANE M,PELLICCIONI M, PINI A, TIZIANO FD, VILLANOVA M,VITA G., BRAHE C (2006). Randomized, double-blind,placebo-controlled trial of phenylbutyrate in spinalmuscular atrophy. In: -. Roma, 24-27 maggio 2006-, vol.16, p. 51-51, ISBN/ISSN: 1120-9992

MESSINA S., BITTO A, AGUENNOUZ M, MINUTOLI L,MONICI MC, ALTAVILLA D, SQUADRITO F, VITA G(2006). Nuclear factor kappa-B blockade reduces skeletal

- 20 -

muscle degeneration and enhances muscle function in Mdxmice. EXPERIMENTAL NEUROLOGY, vol. 198; p. 234-241,ISSN: 0014-4886

MERCURI E, MESSINA S., BATTINI R, BERARDINELLI A,BOFFI P, BONO R, BRUNO C, CARBONI N, CINI C,COLITTO F, D'AMICO A, MINETTI C, MIRABELLA M,MONGINI T, MORANDI L, DLAMINI N, ORCESI S,PELLICCIONI M, PANE M, PINI A, SWAN AV, VILLANOVAM, VITA G., MAIN A, MUNTONI F, BERTINI E (2006).Reliability of the Hammersmith functional motor scale forspinal muscular atrophy in a multicentric study.NEUROMUSCULAR DISORDERS, vol. 16; p. 93-98, ISSN:0960-8966

MESSINA S., ALTAVILLA D, AGUENNOUZ M, SEMINARAP, MINUTOLI L, MONICI MC, BITTO A, MAZZEO A,MARINI H, SQUADRITO F, VITA G (2006). Lipidperoxidation inhibition blunts nuclear factor-kappa Bactivation, reduces skeletal muscle degeneration, andenhances muscle function in mdx mice. AMERICANJOURNAL OF PATHOLOGY, vol. 168; p. 918-926, ISSN:0002-9440

KINALI M, MESSINA S., MERCURI E, LEHOVSKY J, EDGEG, MANZUR AY, MUNTONI F (2006). Management ofscoliosis in Duchenne Muscular Dystrophy: a large 10-yearretrospective study. DEVELOPMENTAL MEDICINE ANDCHILD NEUROLOGY, vol. 48; p. 513-518, ISSN:0012-1622

MERCURI E, D'AMICO A, TESSA A, BERARDINELLI A,PANE M, MESSINA S., VAN REEUWIJK J, BERTINI E,MUNTONI F, SANTORELLI FM (2006). POMT2 mutationin a patient with 'MEB-like' phenotype.NEUROMUSCULAR DISORDERS, vol. 16; p. 446-448,ISSN: 0960-8966

PANE M, VASTA I, MESSINA S., SORLETI D, ALOYSIUSA, SCIARRA F, MANGIOLA F, KINALI M, RICCI E,MERCURI E (2006). Feeding problems and weight gain inDuchenne muscular dystrophy. EUROPEAN JOURNAL OFPAEDIATRIC NEUROLOGY, vol. 10; p. 231-236, ISSN:1090-3798

KINALI M, MAIN M, ELIAHOO J, MESSINA S., Mercuri E,

- 21 -

Banks L, Manzur AY, Muntoni F. (2006). Predictive factorsfor the development of scoliosis in Duchenne MuscularDystrophy. NEUROMUSCULAR DISORDERS; p. 713-713,ISSN: 0960-8966

MESSINA S., Bitto A, Aguennouz M, Migliorato A, DePasquale MG, Minutoli L, Altavilla D, Zentilin L, Giacca M,Squadrito F, Vita G. (2006). Vascular endothelial growthfactor gene transfer using adeno-associated viral vectorsstimulates skeletal muscle regeneration and enhancesmuscle function in mdx mice. NEUROMUSCULARDISORDERS; p. 713-713, ISSN: 0960-8966

MESSINA S., BITTO A., AGUENNOUZ M, MINUTOLI L,MONICI MC, ALTAVILLA D, SQUADRITO F, VITA G(2006). Nuclear factor kappa-B blockade reduces skeletalmuscle degeneration and enhances muscle function in mdxmice. EXPERIMENTAL NEUROLOGY, vol. 198; p. 234-241,ISSN: 0014-4886

MESSINA S. (2006). Vascular endothelial growth factorgene transfer using adeno-associated viral vectorsstimulates skeletal muscle regeneration and enhancesmuscle function in mdx mice. BASIC AND APPLIEDMYOLOGY; p. 10-10, ISSN: 1120-9992

MESSINA S., AGUENNOUZ M, MACELLANI N, MONICIMC, ARCELLI D, SEMINARA P, VOLINIA S, VITA GL,RUSSO M, SQUADRITO F, VITA G. (2005). Effects ofNF-kB blockade on muscle gene expression in mdx mice.In: -. Cernobbio, 8-12 ottobre 2005, vol. 26(Suppl.), p.S9-S9, ISBN/ISSN: 1590-1874

RODOLICO C, MAZZEO A, TOSCANO A, MESSINA S.,AGUENNOUZ M, GAETA M, MESSINA C, VITA G. (2005).Specific matrix metalloproteinase expression in focalmyositis: an immunopathological study. ACTANEUROLOGICA SCANDINAVICA, vol. 112; p. 173-177,ISSN: 0001-6314, doi: 10.1111/j.1600-0404.2005.00457.x

AGUENNOUZ M, MESSINA MF, RODOLICO C, MESSINAS., VALENZISE M, CRISAFULLI G, VITA G. (2005).Dystrophin gene and SHOX gene mutations in a child withBecker muscular dystrophy and short stature. In: -. Ischia,16-18 GIUGNO 2005, vol. 15, p. 96-96, ISBN/ISSN:1120-9992

- 22 -

MESSINA S., AGUENNOUZ M, MACELLANI M, MONICIMC, ARCELLI D, SEMINARA P, VOLINIA S, SQUADRITOF, VITA G. (2005). Effects of NF-kB blockade on musclegene expression in mdx mice. In: -. Ischia, 16-18 GIUGNO2005, vol. 15, p. 109-109, ISBN/ISSN: 1120-9992

BERTINI E, MESSINA S., BATTINI R, BERARDINELLI A,BOFFI P, BRUNO C, CINI C, COLITTO F, DAMICO A,MINETTI C, MIRABELLA M, MONGINI T, MORANDI L,ORCESI S, PELLICCIONI M, PINI A, SWAN AV,VILLANOVA M, VITA G., MAIN M, MERCURI E (2005).Reliability of the Hammersmith functional motor scale in amulticentric study. In: Basic and Applied Myology. Ischia,16-18 GIUGNO 2005, vol. 15, p. 98-98, ISBN/ISSN:1120-9992

BITTO A, ALTAVILLA D, MINUTOLI L, MESSINA S.,AGUENNOUZ M, MONICI MC, MARINI H, VITA G,SQUADRITO F (2005). Lipid peroxidation inhibition bluntsNuclear Factor kappa-B activation, reduces skeletalmuscle degeneration and enhances muscle function in mdxmice. In: -. Napoli, 1-4 giugno 2005, p. 103-103

VASTA I, KINALI M, MESSINA S., GUZZETTA A,KAPELLOU O MANZUR AY, COWAN F, MUNTONI F,MERCURI E (2005). Hypotonia does not equal weakness:diagnostic consideration on a large cohort of neonatesreferred for a suspected neuromuscular condition. Canclinical signs identify newborns with neuromusculardisorders?. JOURNAL OF PEDIATRICS, vol. 146; p. 73-79,ISSN: 0022-3476

MERCURI E, BROWN SC, NIHOYANNOPOULOS P,POULTON J, KINALI M, RICHARD P, PIERCY RJ,MESSINA S., SEWRY C, BURKE MM, MCKENNA W,BONNE G, MUNTONI F (2005). Extreme variability ofskeletal and cardiac muscle involvement in patients withmutations in exon 11 of the lamin A/C gene. MUSCLE &NERVE, vol. 31; p. 602-609, ISSN: 0148-639X

TOSCANO A, MESSINA S., CAMPO G M, DI LEO R,MUSUMECI O, RODOLICO C, AGUENNOUZ A, ANNESIG, MESSINA C, VITA G (2005). Oxidative stress inmyotonic dystrophy type 1. FREE RADICAL RESEARCH,vol. 39; p. 771-776, ISSN: 1071-5762

- 23 -

RODOLICO C, MAZZEO A, TOSCANO A, MESSINA S.,AGUENNOUZ M, GAETA M, MESSINA C, VITA G (2005).Specific matrix metalloproteinase expression in focalmyositis: an immunopathological study. ACTANEUROLOGICA SCANDINAVICA, vol. 112; p. 173-177,ISSN: 0001-6314

JUNGBLUTH H, ZHOU H, HARTLEY L,HALLIGER-KELLER B, MESSINA S., LONGMAN C,BROCKINGTON M, ROBB SA, STRAUB V, VOIT T, SWASHM, FERREIRO A, BYDDER G, SEWRY CA, MULLER C,MUNTONI F (2005). Minicore myopathy withophthalmoplegia caused by mutations in the ryanodinereceptor type 1 gene. NEUROLOGY, vol. 65; p. 1930-1935,ISSN: 0028-3878

RODOLICO C, TOSCANO A, PATITUCCI A, MUGLIA M,GAETA M, D'ARRIGO G, MIGLIORATO A, MESSINA S.,QUATTRONE A, MESSINA C, VITA G. (2005). Clinical andmuscle magnetic resonance imaging study of an Italianfamily with autosomal dominant inclusion body myopathynot linked to known genetic loci. NEUROLOGICALSCIENCES, vol. 26; p. 303-309, ISSN: 1590-1874, doi:10.1007/s10072-005-0502-x

MERCURI E, PANE M, MESSINA S., MUNTONI F (2005).Nuovi meccanismi nelle distrofie muscolari: i difetti diglicosilazione dell’ α-distroglicano. PROSPETTIVE INPEDIATRIA, vol. 35; p. 295-302, ISSN: 0301-3642

DLAMINI N, MESSINA S., PADUA D.L. Kinali M, Main M,Muntoni F, Mercuri E (2005). Quality of life outcomesfollowing rehabilitation in knee-ankle-foot orthoses(KAFOs) in Duchenne muscular dystrophy.NEUROMUSCULAR DISORDERS; p. 701-701, ISSN:0960-8966

MESSINA S., AGUENNOUZ M, MACELLANI N, MONICIMC, ARCELLI D, SEMINARA P, VOLINIA S, SQUADRITOF, VITA G. (2005). Effects of NF-kB blockade on musclegene expression in mdx mice. NEUROMUSCULARDISORDERS, vol. 15; p. 713-713, ISSN: 0960-8966

TOSCANO A, MESSINA S., CAMPO GM, DI LEO R,MUSUMECI O, RODOLICO C, AGUENNOUZ M, ANNESI

- 24 -

G, MESSINA C, VITA G. (2005). Oxidative stress inmyotonic dystrophy type 1. FREE RADICAL RESEARCH,vol. 39; p. 771-776, ISSN: 1071-5762

MERCURI E, PANE M, MESSINA S., MUNTONI F. (2005).Nuovi meccanismi nelle distrofie muscolari: i difetti diglicosilazione dell’ α-distroglicano. PROSPETTIVEIN PEDIATRIA, vol. 35; p. 295-302, ISSN: 0301-3642

MESSINA MF, M. AGUENNOUZ, VALENZISE M., CRODOLICO, MESSINA S., G CRUISAFULLI, G VITA, F DELUCA (2005). Dyscondrosteosis in a child with Beckermuscular dystrophy: an unreported association betweenXp21 gene (DMD/BMD) deletion and a novel homozygousSHOX gene mutation. In: Hormone Research. Lyon,France, September 21-24,2005-, vol. 64(1), p. 186-

STEFFENSEN BF, MAYHEW A, ALOYSIUS A, EAGLE M,MERCURI E, MESSINA S. (2004). Egen classificationrevisited in SMA. NEUROMUSCULAR DISORDERS, vol.18; p. 735-735, ISSN: 0960-8966

TIZIANO F.D, VITALI T, ANGELOZZI C, MESSINA S.,BRAHE C (2004). Phenylbutyrate increases SMN geneexpression and motor function in spinal muscular atrophypatients. EUROPEAN JOURNAL OF HUMAN GENETICS;p. 64-64, ISSN: 1018-4813

Jungbluth H, Zhou H, Hartley L, Halliger-Keller B,MESSINA S., Longman C, Brockington M, Robb SA,Straub V, Voit T, Swash M, Ferreiro A, Bydder G, SewryCA, Muller C, Muntoni F. (2004). Minicore myopathy withophthalmoplegia caused by mutations in the ryanodinereceptor type 1 gene. DEVELOPMENTAL MEDICINE ANDCHILD NEUROLOGY; p. S98-S98, ISSN: 0012-1622

M. Kinali, I. Vasta, O. Kapellou, MESSINA S., A. Guzzetta,F. Cowan, AY Manzur, E. Mercuri, F Muntoni. (2004).Hypotonia does not equal primary neuromusculardisorder: diagnostic outcomes on a large cohort ofneonates referred for a suspected neuromuscularcondition. . DEVELOPMENTAL MEDICINE AND CHILDNEUROLOGY; p. S98-S98, ISSN: 0012-1622

MESSINA S., SEMINARA P, AGUENNOUZ M, ET AL(2004). NF-kB blockade reduces skeletal muscle

- 25 -

degeneration and enhances muscle function in mdx mice.In: Neuromuscul Disord. Goteborg, 4 September 2004, p.624

MESSINA S., HARTLEY L, MAIN M, Kinali M, Mercuri E,Main M, Stephens OA, Muntoni F. (2004). Pilot trial ofsalbutamol in congenital myopathies. In: J Neurol.Taormina, Italy, 01/10/2004, p. 77-77

MESSINA S., SEMINARA P, AGUENNOUZ M, ET AL(2004). Effect of tratment with PDTC and IRFI 042 onstrenght and fatigue in mdx mice. In: J Neurol. Taormina,Italy, 10/06/2004, p. 78

MERCURI E, BERTINI E, TIZIANO F. D, VITALI T,ANGELOZZI C, MESSINA S., BRAHE C. (2004).Phenylbutyrate in non-ambulant SMA II/III: from an opentrial to a double-blind study. In: -. Schaumburg, IL,, June2004, p. 221-221

RODOLICO C., MESSINA S., TOSCANO A., VITA G.,GAETA M. (2004). Axial myopathy in myasthenia: amisleading cause of dropped head. MUSCLE & NERVE,vol. 29; p. 329-330, ISSN: 0148-639X, doi:10.1002/mus.10543

MERCURI E, BERTINI E, MESSINA S., PELLICCIONI M,DAMICO A, COLITTO F, MIRABELLA M, TIZIANO FD,VITALI T, ANGELOZZI C, KINALI M, MAIN M, BRAHE C(2004). Pilot trial of phenylbutyrate in spinal muscularatrophy. NEUROMUSCULAR DISORDERS, vol. 14; p.124-129, ISSN: 0960-8966

MERCURI E, MESSINA S., KINALI M, CINI C, BATTINI R,CIONI G, MUNTONI F (2004). Congenital form of distalspinal muscular atrophy affecting the lower limbs: acommon condition in childhood. NEUROMUSCULARDISORDERS, vol. 14; p. 130-135, ISSN: 0960-8966

MERCURI E, POPPE M, QUINLIVAN R, MESSINA S.,KINALI M, DEMAY L, BOURKE J, RICHARD P, SEWRY C,PIKE M, BONNE G, MUNTONI F, BUSHBY K (2004).Extreme variability of phenotype in patients with anidentical missense mutation in the lamin A/C gene: from

- 26 -

congenital onset with severe phenotype to milder classicalEmery-Dreifuss variant. ARCHIVES OF NEUROLOGY, vol.61; p. 690-694, ISSN: 0003-9942

MESSINA S., HARTLEY L, MAIN M, KINALI M,JUNGBLUTH H, MUNTONI F, MERCURI E (2004). Pilottrial of salbutamol in minicore and central core diseases.NEUROPEDIATRICS, vol. 5; p. 262-266, ISSN: 0174-304X

JUNGBLUTH H, DAVIS MR, MULLER C, COUNSELL S,ALLSOP J, CHATTOPADHYAY A, MESSINA S., MERCURIE, LAING NG, SEWRY CA, BYDDER G, MUNTONI F(2004). Magnetic resonance imaging of muscle incongenital myopathies associated with RYR 1 mutations.NEUROMUSCULAR DISORDERS, vol. 65; p. 1930-1935,ISSN: 0960-8966

MESSINA S., MERCURI E, MUNTONI F (2004). Distrofiemuscolari congenite. GIORNALE DI NEUROPSICHIATRIADELL'ETÀ EVOLUTIVA, vol. 24; p. 281-296, ISSN:0392-4483

MESSINA S., Altavilla D, Aguennouz M, Seminara P,Minutoli L, Monici MC, Bitto A, Mazzeo A, Squadrito F,Vita G. (2004). NF-kB blockade reduces skeletal muscledegeneration and enhances muscle function in mdx.NEUROLOGICAL SCIENCES; p. S25-S25, ISSN:1590-1874

MESSINA S., HARTLEY L, Mercuri E, Main M, StephensOA, Muntoni F. (2004). Pilot trial of salbutamol incongenital myopathies. NEUROMUSCULAR DISORDERS;p. 597-597, ISSN: 0960-8966

MESSINA S., HARTLEY L, Mercuri E, Main M, StephensOA, Muntoni F. (2004). Pilot trial of salbutamol incongenital myopathies. BASIC AND APPLIED MYOLOGY;p. 120-120, ISSN: 1120-9992

MESSINA S., Altavilla D, Aguennouz M, Seminara P,Minutoli L, Monici MC, Bitto A, Mazzeo A, Marini H,Squadrito F, Vita G. (2004). Effect of treatment with PDTCand IRFI 042 on strenght and fatigue in mdx mice. BASICAND APPLIED MYOLOGY; p. 120-120, ISSN: 1120-9992

MESSINA S., SEMINARA P, AGUENNOUZ M, MONICI

- 27 -

MC, H. MARINI, SQUADRITO F, VITA G (2004). NF-kBblockade reduces skeletal muscle degeneration andenhances muscle function in mdx mice.NEUROMUSCULAR DISORDERS, vol. 14; p. 624-624,ISSN: 0960-8966

MESSINA S., SEMINARA P, AGUENNOUZ M, MONICIMC, H. MARINI, SQUADRITO F, VITA G (2004). EFFECTOF TREATMENT WITH PDTC AND IRFI 042 ONSTRENGTH AND FATIGUE IN MDX MICE. JOURNAL OFNEUROLOGY, vol. 251 (Suppl. 3); p. 78-78, ISSN:0340-5354

AGUENNOUZ M, MUSUMECI O, RODOLICO C, MESSINAS., TOSCANO A, MONICI MC, BUEMI C, CIRANNI A, VITAG (2003). Expression of the trascription factor NFkB indifferent muscular dystrophies. BASIC AND APPLIEDMYOLOGY; p. 223-223, ISSN: 1120-9992

MERCURI E, CINI C, PICHIECCHIO A, ALLSOP J,COUNSELL S, ZOLKIPLI Z, MESSINA S., KINALI M,BROWN SC, JIMENEZ C, BROCKINGTON M, YUVA Y,SEWRY CA, MUNTONI F (2003). Muscle MagneticResonance Imaging in patients with congenital musculardystrophy and Ulrich phenotype. NEUROMUSCULARDISORDERS, vol. 13; p. 554-558, ISSN: 0960-8966

AGUENNOUZ M, MUSUMECI O, RODOLICO C, MESSINAS., TOSCANO A, MONICI MC, BUEMI C, CIRANNI A, VITAG (2003). Expression of the trascription factor NFkB indifferent muscular dystrophies. In: Basic and AppliedMyology. Padua, Italy, 12-15 June 2003, p. 223

MESSINA S., KINALI M, MERCURI E, PADUA L, MAIN M,MUNTONI F. (2003). Gli strumenti di QoL nelle patologieneuromuscolari ed esperienze preliminari sullo sviluppo diun questionario specifico per la di un questionariospecifico per la distrofia muscolare di Duchenne.NEUROLOGICAL SCIENCES, vol. 24; p. S746-S749, ISSN:1590-1874

MESSINA S., KINALI M, MERCURI E, BANKS L, MANZURAY, MUNTONI F. (2003). Bone mineral densitymeasurement in children with Duchenne muscular

- 28 -

dystrophy: effect of low dose intermittent prednisolone.BASIC AND APPLIED MYOLOGY; p. 238-238, ISSN:1120-9992

MERCURI E, MESSINA S., KINALI M, CINI C, BATTINI R,CIONI G, MUNTONI F. (2003). Congenital form of distalspinal muscular atrophy affecting the lower limbs: acommon condition in childhood. BASIC AND APPLIEDMYOLOGY; p. 236-236, ISSN: 1120-9992

MESSINA S., KINALI M, MERCURI E, LEHOVSKY J, EDGEG, MANZUR AY, MUNTONI F (2003). Management ofscoliosis in Duchenne muscular dystrophy: a 10 yearretrospective study. . NEUROLOGICAL SCIENCES; p.S52-S52, ISSN: 1590-1874

KINALI M, MESSINA S., MERCURI E, STEPHENS DA,JAYWANT S, MANZUR AY, BANKS L, MUNTONI F. (2003).Bone mineral density measurement in children withDuchenne muscular dystrophy: effect of low doseintermittent prednisolone.. NEUROMUSCULARDISORDERS; p. 626-626, ISSN: 0960-8966

RODOLICO C, MESSINA S., SINICROPI S, TOSCANO A,GAETA M, DARRIGO G, VITA G. (2003). Axial myopathy inmyasthenia: a misleading cause of dropped head..NEUROLOGICAL SCIENCES; p. 198-198, ISSN:1590-1874

HARTLEY L, MESSINA S., KINALI M, MERCURI E, MAINM, STEPHENS OA, MUNTONI F. (2003). Pilot trial ofsalbutamol in structural congenital myopathies. .EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY; p.332-332, ISSN: 1090-3798

VASTA I, KINALI M, KAPELLOU O, MESSINA S.,GUZZETTA A, MANZUR AY, COWAN F, MUNTONI F,MERCURI E. (2003). Hypotonia does not equal weakness:diagnostic consideration on a large cohort of neonatesreferred for a suspected neuromuscular condition.EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY; p.110-110, ISSN: 1090-3798

MESSINA S., KINALI M, MERCURI E, LEHOVSKY J, EDGEG, MANZUR AY, MUNTONI F (2003). Aguennouz M,Musumeci O, Rodolico C, Messina S, Toscano A, Monici

- 29 -

MC, Buemi C, Ciranni A, Vita G. In: Basic and AppliedMyology. Padua, Italy, 12-15 June 2003, p. 223

MONICI MC, RODOLICO C, TOSCANO A, MESSINA S.,BENVENGA S., MESSINA C, VITA G (2002). Apoptosis andapoptosis-related proteins in thyroid myopathies. MUSCLE& NERVE, vol. 26; p. 383-388, ISSN: 0148-639X

KINALI M, MESSINA S., MERCURI E, MANZUR AY,DUBOWITZ V, MUNTONI F. (2002). Spinal surgery is notalways essential in management of scoliosis in Duchennemuscular dystrophy. NEUROMUSCULAR DISORDERS; p.738-738, ISSN: 0960-8966

RODOLICO C., TOSCANO A, AUTUNNO M, MESSINA S.,NICOLOSI C, AGUENNOUZ M, LAURA M, GIRLANDA P,MESSINA C, VITA G (2002). Limb-girdle myasthenia:clinical, electrophysiological and morphological features infamilial and autoimmune cases. NEUROMUSCULARDISORDERS, vol. 12; p. 964-969, ISSN: 0960-8966